Access

Article

Nature 431, 1112-1117 (10 October 2004) | doi:10.1038/nature03043;

Open Innovation Challenges

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

Hepatocellular carcinoma is generally refractory to clinical treatment. Here, we report that inactivation of the MYC oncogene is sufficient to induce sustained regression of invasive liver cancers.

, , , , , , , , , , , , &

Top